Roy Luo - Oct 21, 2021 Form 3 Insider Report for Enfusion, Inc. (ENFN)

Role: Director
Signature: /s/ Roy Luo
Stock symbol: ENFN
Transactions as of: Oct 21, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/21/2021, 09:39 PM
Next filing: Oct 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENFN	Class A Common Stock						7.75M	Oct 21, 2021	By ISP V-B EF LP	F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENFN	Common Units of Enfusion Ltd. LLC							Oct 21, 2021	Class A Common Stock	5.03M		By ISP V Main Fund EF LLC	F2, F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by ISP V-B EF LP ("ISP V-B EF").
F2	The shares are held by ISP V Main Fund EF LLC ("ISP V EF").
F3	ICONIQ Strategic Partners V, L.P. ("ICONIQ V") is the sole managing member of ISP V EF. ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V and ISP V-B EF. ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP.
F4	The Reporting Person is an investor at ICONIQ Capital and may have limited partner or other interests in one or more of the entities described herein. The Reporting Person disclaims Section 16 beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or any other purpose.
F5	Common Units of Enfusion Ltd. LLC (the "Common Units") are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis (for which the Issuer may substitute cash) following the completion of the Issuer's initial public offering. The Common Units have no expiration date. At the time of any such exchange, an equal number of shares of Class B common stock of the Issuer held by the Reporting Person, which have no economic value and entitle holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally, are cancelled.